Global and US trends, in addition to US government regulations, often are inexorably linked in healthcare. Looking to 2016, the biggest issue both worldwide and in the US continues to be cost. All other trends stem from the cost factor, including access to care, advances in care (especially new drugs), accountable care/alternative payment models, and digital consumer engagement.

The global medical aesthetics market is estimated to grow at a CAGR of 10.8% in the forecast period. The increasing demand of minimally invasive and non-invasive aesthetic procedures, technological advancements in energy based devices, and rapid growth in number of cosmetic procedures are the key factors fueling the growth of the medical aesthetics market. Studies made on the global medical aesthetics market over the forecast period of 2015 to 2020. The market is expected to reach ~$12,581.9 Million by 2020, at a CAGR of 10.8% from 2015 to 2020.

Despite spending upwards of 18 percent of GDP on health care, comparative analyses consistently show the US underperforms relative to other countries on most dimensions of performance—such as efficiency, access, equity, and outcomes. In addition, an estimated 34 million people in the US still lack health insurance and, therefore, access to care outside of emergency departments. Yet regardless of political leanings, the ACA has eased the situation somewhat by driving market changes intended to encourage new ways of delivering and reimbursing care.

Many organizations in the provider sector are tracking on two additional factors that may greatly impact the health care ecosystem: the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and the Cadillac Tax.
MACRA signed into law by President Obama. This law sets updates under the Medicare physician fee schedule for all years in the future, beginning at 0.5 percent from 2015 through 2018. Payment rates will be flat from 2019 through 2025. Beginning in 2026, professionals participating in eligible alternative payment models will receive annual payment updates of 0.75 percent, while other providers will receive annual payment updates of 0.25 percent. Physician costs will likely rise more than that.

TRENDS
Health and beauty specialist retailers are strengthening their relationships with health care providers to support sales. With the new requirements of the Affordable Care Act, health records and related documents are becoming available electronically. As a result, health providers can use the internet to send prescriptions directly to retailers. Consumers can decide which retailer they want to use although some health providers are making it difficult for consumers to obtain a written prescription to take with them. This is favoring drugstores/para-pharmacies more than other health retailers because of this direct contact with health providers.

COMPETITIVE LANDSCAPE
Walgreen and CVS Health Corp led health and beauty specialist retailers in 2015 with respective value shares of 27% and 23%. This can be attributed to drugstores/para-pharmacies dominating the wider health and beauty landscape, accounting for a 73% share of overall value sales in 2015. In terms of outlets, these two retailers together held a 17% share.

PROSPECTS
Health and beauty specialist retailers is expected to post a value CAGR of 2% at constant 2015 prices over the forecast period. This growth will likely primarily be driven by beauty specialist retailers as a result of increasing consumer demand for beauty products and a rise in the number of outlets. Drugstores/para-pharmacies will remain the largest channel in terms of value sales. These retailers are likely to continue to aggressively compete for Rx drugs sales through relationships with health providers. In addition, they are likely to benefit from additional services such as on-site clinics.